Concepedia

Utilization of an Amorphous Form of a Water-Soluble GPIIb/IIIa Antagonist for Controlled Release from Biodegradable Microspheres

Shigeyuki Takada, Tomofumi Kurokawda, Keiko Miyazaki, Susumu Iwasa, Yasuaki Ogawa

Pharmaceutical Research · 1997 · 36 citations · 17 references

DOI

Concepts

References

17

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

, , +17

Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) Microspheres

Lynda M. Sanders, John S. Kent, G.I. McRae et al. · Journal of Pharmaceutical Sciences · 1984 · 251 citations

, , +16

The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation Method

Roland Bodmeier, James W. McGinity · Pharmaceutical Research · 1987 · 197 citations

, , +13

Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer.

Yasuaki Ogawa, Masaki Yamamoto, Shigeyuki Takada et al. · Chemical and Pharmaceutical Bulletin · 1988 · 174 citations · Full text

, , +17

MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.

Kathelijne Peerlinck, Inge De Lepeleire, Michael R. Goldberg et al. · Circulation · 1993 · 164 citations · Full text

, , +17